BrainStorm

Investors & Media

Investors & Media

BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Upcoming Events
More events are coming soon.
Tools
Email Alerts
Investor Contact
Investor FAQs
RSS Feeds